Compositions and methods for assessing and treating adrenal diseases and disorders
The present invention relates to the discovery that mutations in KCNJ5 are associated with adrenal diseases and disorders. The invention includes compositions and methods for the assessment, characterization and treatment of adrenal diseases and disorders, based upon the presence or absence of a KCNJ5 mutation that is associated with an adrenal disease or disorder.
1. A method of diagnosing and treating an adrenal disease or disorder in a human subject in need thereof, the method comprising:
a. detecting at least one mutation in the subject's KCNJ5 sequence in a biological sample of the subject, wherein said at least one mutation is G151R, L168R, T158A or E145Q;
b. diagnosing the subject a having an adrenal disease or disorder; and
c. administering to the subject a treatment for the adrenal disease or disorder.
2. The method of claim 1 , wherein the subject's KCNJ5 sequence is a nucleic acid sequence, and wherein the nucleic acid sequence encodes a polypeptide.
3. The method of claim 1 , wherein the subject's KCNJ5 sequence is an amino acid sequence.
4. The method of claim 1 , wherein said step of detecting at least one mutation in the subject's KCNJ5 sequence employs PCR.
5. The method of claim 1 , wherein the biological sample is at least one selected from the group consisting of: blood, plasma, serum, a body fluid, a tissue, a tumor, and a cell.
6. The method of claim 1 , wherein the adrenal disease or disorder is at least one disease or disorder selected from the group consisting of aldosteronism, primary aldosteronism, secondary aldosteronism, hyperaldosteronism, primary hyperaldosteronism, secondary hyperaldosteronism, adrenal insufficiency, Addison's Disease, adrenoleukodystrophy, pheochromocytoma, Cushing's Syndrome, adrenal hyperplasia, congenital adrenal hyperplasia, cancer, adrenal cancer, hypertension, primary hypertension, secondary hypertension and virilization.